Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

Mov Disord. 2000 May;15(3):579-81. doi: 10.1002/1531-8257(200005)15:3<579::AID-MDS1024>3.0.CO;2-0.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antiparkinson Agents / adverse effects*
  • Antiparkinson Agents / therapeutic use
  • Antipsychotic Agents / administration & dosage*
  • Antipsychotic Agents / adverse effects
  • Clozapine / administration & dosage*
  • Clozapine / adverse effects
  • Dibenzothiazepines / administration & dosage*
  • Dibenzothiazepines / adverse effects
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Middle Aged
  • Psychiatric Status Rating Scales
  • Psychoses, Substance-Induced / drug therapy*
  • Quetiapine Fumarate
  • Treatment Outcome

Substances

  • Antiparkinson Agents
  • Antipsychotic Agents
  • Dibenzothiazepines
  • Quetiapine Fumarate
  • Clozapine